Dose-dense (dd) doxorubicin-cyclophosphamide (AC) X 4 and short-term changes in left ventricular ejection fraction (LVEF) alone or with bevacizumab (B) in patients (pts) with early stage breast cancer (BC) Meeting Abstract


Authors: Morris, P. G.; Dickler, M. N.; McArthur, H. L.; Traina, T. A.; Nulsen, B.; Steingart, R. M.; Rugo, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
Abstract Title: Dose-dense (dd) doxorubicin-cyclophosphamide (AC) X 4 and short-term changes in left ventricular ejection fraction (LVEF) alone or with bevacizumab (B) in patients (pts) with early stage breast cancer (BC)
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 40s
Language: English
ACCESSION: WOS:000208457400074
DOI: 10.1200/jco.2008.26.15_suppl.637
PROVIDER: wos
Notes: Meeting Abstract: 637 -- Source: Wos
Altmetric Score
MSK Authors
  1. Patrick Glyn Morris
    107 Morris
  2. Clifford Hudis
    838 Hudis
  3. Larry Norton
    557 Norton
  4. Chau Dang
    156 Dang
  5. Maura N Dickler
    237 Dickler
  6. Richard M Steingart
    113 Steingart
  7. Tiffany A Traina
    153 Traina
  8. Benjamin Francis Nulsen
    8 Nulsen